Skip to content

VRC01 antibody delays but does not prevent HIV rebound after antiretroviral treatment interruption

Katharine Bar presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

Gene therapy snips HIV out of infected cells and makes uninfected cells resistant

Experimental TLR7 agonist suppresses HIV-like virus in monkeys after ART interruption

Study does not support routine HPV quadrivalent vaccination to protect against anal cancer in older people living with HIV

Dose-finding trials of antibody-based drugs for HIV prevention will start soon

John Mascola presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

HIV-infected vaginal cells do not transmit HIV if plasma viral load is undetectable, researchers find

Combination nanotherapy drastically reduces the amount of HIV produced by cells in mice

Model suggests HIV vaccine still has key role in ending AIDS

Two cases of PrEP failure on solo tenofovir pose significant research questions